OptiBiotix Health PLC Appoints New Broker
The life sciences company has appointed Cairn Financial Advisers LLP as its new broker.
The life sciences company has appointed Cairn Financial Advisers LLP as its new broker.
The life sciences company reported a 35% revenue increase but faced widening losses and margin pressure. Despite growth in key markets, economic uncertainties and supply chain challenges pose risks to future performance.
The healthcare company has announced the publication of a new study on its SlimBiome product in a prestigious scientific journal, providing further evidence of the product's efficacy.
The life sciences company has raised £750,000 through a discounted share placing to fund its expansion into the US market, but the significant discount raises concerns about investor appetite.
The life sciences company has launched its SlimBiome products with a NASDAQ-listed US partner, expanding its reach in the weight management market.
The life sciences company has received its first order from a leading US weight management brand to incorporate its SlimBiome product into a range of flavored drinks.
The life sciences company reports progress on key strategic objectives, including increasing partners and sales in the USA and Asia, investing in e-commerce, and growing sales of branded and white label products.
The life sciences company has launched a new weight management product in the US, partnering with a prominent brand to drive sales.
Life sciences company launches weight management products on Amazon India, expanding reach in a key market.
Biotechnology company appoints new Finance Director to improve financial management and drive profitability.